Methysergide Maleate

马来酸美西麦角

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMethysergide Maleate
Drug Alias Name二甲麦角新碱methysergidum马来酸二甲麦角新碱metisergida1-甲基-甲基麦角新碱 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin (5-HT) receptor agonists
TargetsSerotonin (5-HT) receptor
Therapy Area/IndicationsCluster HeadacheMigraine Disorders
Global Approved IndicationsCluster HeadacheMigraine Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1962/02/12
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsCluster HeadacheMigraine Disorders

Other Information

ATC CodeN02CA04
Related LinksWikipediaDrugBankKEGG